Peak ages of risk for starting nonmedical use of prescription stimulants
Open accessAbstract
Background To produce population-level, year- and age-specific risk estimates of first time nonmedical use of prescription stimulants among young people in the United States.Methods Data are from the National Surveys on Drug Use and Health 2004-2012; a nationally representative probability sample survey administered each year. Subpopulations included youths aged 12 to 21 years (n=240,160) who had not used prescription stimulants nonmedically prior to their year of survey assessment. A meta-analytic approach was used to produce population-level age-, year-, and cohort-specific risk estimates of first time nonmedical use of prescription stimulants.Results Peak risk of starting nonmedical use of prescription stimulants was concentrated between ages 16 and 19 years, when an estimated 0.7% to 0.8% of young people reported nonmedical use of these medicines for the first time in the past twelve months. Smaller risk estimates ranging from 0.1% to 0.6% were observed at ages 12 to 15 years and 20 to 21 years. Compared with males, females were more likely to have started nonmedical use of prescription stimulants (odds ratio=1.35; 95% CI, 1.13-1.62), particularly between the ages of 14 and 19. Females showed a peak annual incidence rate of 1% at age 18, while males the same age showed an incidence rate of 0.5%.Conclusions Peak annual incidence rates for nonmedical use of prescription stimulants were observed between the ages of 16 and 19 years. There is reason to initiate interventions during the earlier adolescent years to prevent youths from starting nonmedical use of prescription stimulants.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.001 · Cited by 1,263 · see citing works
Metan: fixed- and random-effects meta-analysis
Harris, R. J., Deeks, J. J., Altman, D. G., Bradburn, M. J., Harbord, R. M., & Sterne, J. A. C. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800102 · Cited by 1,027 · see citing works
Data analysis 2Preprint
Wagemans, F. M. A., Brandt, M. J., & Zeelenberg, M. (2016) · Cited by 952 · see citing works
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493 · see citing works
Early-onset drug use and risk for drug dependence problems
Chen, C.-Y., Storr, C. L., & Anthony, J. C. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.10.021 · Cited by 466 · see citing works
Medical Use, Illicit Use and Diversion of Prescription Stimulant Medication
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10399827 · Cited by 305 · see citing works
McCabe, S. E., West, B. T., Morales, M., Cranford, J. A., & Boyd, C. J. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02015.x · Cited by 293 · see citing works
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003) · Pediatrics · doi:10.1542/peds.111.1.97 · Cited by 274 · see citing works
McCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.03.008 · Cited by 268 · see citing works
Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07091465 · Cited by 263 · see citing works
Katusic, S. K., Barbaresi, W. J., Colligan, R. C., Weaver, A. L., Leibson, C. L., & Jacobsen, S. J. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.764 · Cited by 175 · see citing works
Medical and Nonmedical Use of Prescription Stimulants: Results From a National Multicohort Study
McCabe, S. E., & West, B. T. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.005 · Cited by 92 · see citing works
Kaloyanides, K. B., McCabe, S. E., Cranford, J. A., & Teter, C. J. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.5.666 · Cited by 88 · see citing works
Coming to terms with the nonmedical use of prescription medications
Boyd, C. J., & McCabe, S. E. (2008) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-3-22 · Cited by 79 · see citing works
Stimulant Prescription Cautions: Addressing Misuse, Diversion and Malingering
Rabiner, D. L. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0375-2 · Cited by 70 · see citing works
Extramedical Use of Prescription Pain Relievers by Youth Aged 12 to 21 Years in the United States
Meier, E. A., Troost, J. P., & Anthony, J. C. (2012) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2012.209 · Cited by 50 · see citing works
Age and Cohort Patterns of Medical and Nonmedical Use of Controlled Medication Among Adolescents
Austic, E. A., McCabe, S. E., Stoddard, S. A., Ngo, Q. E., & Boyd, C. J. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000142 · Cited by 25 · see citing works
Self-citationToward primary prevention of extra-medical OxyContin® use among young people
DeAndrea, D. C., Troost, J. P., & Anthony, J. C. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.05.004 · Cited by 18 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Kroutil L Colliver J Gfroerer J 2010 Age and Cohort Patterns of Substance Use Among Adolescents. OAS Data Review (Office of Applied Studies) Substance Abuse and Mental Health Services Administratio Rockville, MD 1 9
- Substance Abuse and Mental Health Services Administration (SAMHSA) 2014 National Survey on Drug Use and Health (NSDUH) Methodological Resource Book Rockville, MD 30199189
Cited by
Sorted by citations
Crunelle, C., van den Brink, W., Moggi, F., Konstenius, M., Franck, J., Levin, F., van de Glind, G., Demetrovics, Z., Coetzee, C., Luderer, M., et al. (2018) · European Addiction Research · doi:10.1159/000487767 · Cited by 151 · see citing works
Prescription stimulant medication misuse: Where are we and where do we go from here?
Weyandt, L. L., Oster, D. R., Marraccini, M. E., Guðmundsdóttir, B. G., Munro, B. A., Rathkey, E. S., & McCallum, A. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000093 · Cited by 135 · see citing works
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 99 · see citing works
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
(2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001299 · Cited by 78 · see citing works
Prescription Drug Misuse: Taking a Lifespan Perspective
Schepis, T. S., Klare, D. L., Ford, J. A., & McCabe, S. E. (2020) · Substance Abuse Research and Treatment · doi:10.1177/1178221820909352 · Cited by 67 · see citing works
Classics in Chemical Neuroscience: Methylphenidate
Wenthur, C. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00199 · Cited by 65 · see citing works
Winer, J. M., Yule, A. M., Hadland, S. E., & Bagley, S. M. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2104922 · Cited by 65 · see citing works
DSM-5 changes enhance parent identification of symptoms in adolescents with ADHD
Sibley, M. H., & Kuriyan, A. B. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.036 · Cited by 38 · see citing works
Helmer, S. M., Pischke, C. R., Hal, G. F. V., Vriesacker, B., Dempsey, R. C., Akvardar, Y., Guillén‐Grima, F., Salonna, F., Stock, C., & Zeeb, H. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.639 · Cited by 32 · see citing works
McCabe, S. E., Kloska, D. D., Veliz, P. T., Jager, J., & Schulenberg, J. E. (2016) · Addiction · doi:10.1111/add.13504 · Cited by 31 · see citing works
LaBossier, N. J., & Hadland, S. E. (2022) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2022.101265 · Cited by 30 · see citing works
Wu, L., Zhao, D., Lan, Y., Jin, L., & Yang, L. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-00868-5 · Cited by 15 · see citing works
Babicki, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192214879 · Cited by 12 · see citing works
Adorjan, K., & Pogarell, O. M. (2020) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-020-0005-y · Cited by 12 · see citing works
Vosburg, S. K., Faraone, S. V., Newcorn, J. H., Rostain, A. L., Findling, R. L., Butler, S. F., Dailey-Govoni, T., & Green, J. L. (2020) · Journal of Attention Disorders · doi:10.1177/1087054720943283 · Cited by 11 · see citing works
Housman, J. M., Williams, R. D., & Woolsey, C. L. (2016) · American Journal on Addictions · doi:10.1111/ajad.12390 · Cited by 11 · see citing works
McNealy, K. R., Houser, S. D., Barrett, S. T., & Bevins, R. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108845 · Cited by 8 · see citing works
Harton, M. R., Seo, D., Evans‐Polce, R. J., Nguyen, I., & Parker, M. A. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2023.107818 · Cited by 8 · see citing works
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Darling, P. J., Huus, C.-M. L., Zwi, M., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub4 · Cited by 7 · see citing works
Exposure to Medicines in the Family Medicine Cabinet: Is It a Harbinger of Later Opioid Dependence?
Elliott, A. L., Liu, Y., Egan, K. L., Striley, C. W., & Cottler, L. B. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1756856 · Cited by 7 · see citing works
van Kernebeek, M. V., Vorspan, F., Crunelle, C., van den Brink, W., Dom, G., Moggi, F., Konstenius, M., Franck, J., Levin, F., van de Glind, G., et al. (2022) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2022.02.001 · Cited by 4 · see citing works
Les médicaments détournés de leur usage médical par les jeunes : une revue de la littérature
Milhet, M. (2018) · Psychotropes · doi:10.3917/psyt.233.0105 · Cited by 4 · see citing works
Mubarek, Z. W. S., Abbas, F. N., & Al-Agam, A. N. M. (2022) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_228_22 · Cited by 4 · see citing works
Popkin, S., Nanchanatt, A. J., Mauterer, M. I., & Rhoads, D. E. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000405 · Cited by 4 · see citing works
Litt, D., Lowery, A. D., LoParco, C. R., & Lewis, M. A. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106946 · Cited by 4 · see citing works
Sayed, S. M., Ahmad, H. E. K., Sayied, N., & El-Aziz, A. A. (2020) · Assiut Scientific Nursing Journal · doi:10.21608/asnj.2020.79450 · Cited by 1 · see citing works
Adult ADHD in Substance-Related and Addictive Disorders
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_16 · Cited by 1 · see citing works
Merianos, A. L., King, K. A., Vidourek, R. A., Becker, K. J., Yockey, R. A., & Oluwoye, O. A. (2019) · Journal of Child & Adolescent Substance Abuse · doi:10.1080/1067828x.2020.1789523 · Cited by 1 · see citing works
Pediatric Pharmacological Cognitive Enhancement in a Self-Medicating Society
Maier, L. J. (2019) · Advances in neuroethics · doi:10.1007/978-3-030-10677-5_10
ADHS im Erwachsenenalter und komorbide Suchterkrankungen
Adorjan, K., Karch, S., Martin, G., Plörer, D., Winter, C., Hantschk, I., Koller, G., Erbas, B., & Pogarell, O. M. (2019) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-019-0740-0
Helmer, S. M., Czwikla, G., Pischke, C. R., & Zeeb, H. (2020) · Public Health Forum · doi:10.1515/pubhef-2020-0068
Vosburg, S. K., Faraone, S. V., Riley, E. N., Whitaker, T., Kardish, J., Baker, D., Kollins, S. H., & Rush, C. R. (2022) · Journal of Attention Disorders · doi:10.1177/10870547221112948
Will You Tell? Factors Influencing Peer Reporting of Illicit Substance Use: A Mixed-Methods StudyPreprint
Afe, T. O., Fasesan, O. A., Osalusi, B. S., Ale, A. O., & Ogunsemi, O. O. (2024) · Qeios · doi:10.32388/9eqch5
Will You Tell? Factors Influencing Peer Reporting of Illicit Substance Use: A Mixed-Methods StudyPreprint
Afe, T. O., Fasesan, O. A., Osalusi, B. S., Ale, A. O., & Ogunsemi, O. O. (2024) · Qeios · doi:10.32388/9eqch5.2
Will You Tell? Factors Influencing Peer Reporting of Illicit Substance Use: A Mixed-Methods StudyPreprint
Afe, T. O., Fasesan, O. A., Osalusi, B. S., Ale, A. O., & Ogunsemi, O. O. (2024) · Qeios · doi:10.32388/9eqch5.3
COVID-19 Pandemic and Sleep Health in Polish Female Students.
Babicki, M., Witaszek, T., & Mastalerz–Migas, A. (2025) · PubMed Central · doi:10.3390/jcm14155342
Warren, L. K., Delcher, C., Smith, N. I., Adams, J. W., & Bobashev, G. (2026) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2026.2706612
- Authors
- Austic, E. A.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Austic, E.A.
- ORCID
- Austic, E.A.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 152
- Pages
- 224-229
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC4458195
- OpenAlex
- W2068591622
- Cited by
- 38
- References
- 18
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 7 · 2019: 3 · 2018: 3 · 2016: 7
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-02-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000433)
- National Institute on Drug Abuse (K05DA015799, R01DA016558, T32DA021129, T32DA007267, R01DA024678, R01DA036541, R01DA031160)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- stimulant medication, adolescents, young adults, age-specific risk, sex differences, substance use prevention, National Survey on Drug Use and Health
- MeSH terms
- Adolescent, Age Factors, Central Nervous System Stimulants, Female, Health Surveys, Humans, Male, Risk Factors, Self Medication, United States, Incidence, Substance-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
